General - Press Releases

Date	Title	Company
05-Jun-2023	Precision BioSciences to Present at Upcoming June Investor Conferences	Businesswire
05-Jun-2023	Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab	Businesswire
05-Jun-2023	Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™	Businesswire
05-Jun-2023	KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Businesswire
05-Jun-2023	Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β Inhibitor, BCA101, Demonstrates 65% ORR in Combination with Pembrolizumab in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)	Businesswire
05-Jun-2023	Seneca Therapeutics, Inc. Appoints Cuong Do to its Board of Directors	Businesswire
05-Jun-2023	Sustainability as a Success Factor: OQ Chemicals Launches Biobased Oxbalance TCD Alcohol DM	Businesswire
05-Jun-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
05-Jun-2023	Pherecydes Announces That Legal Proceedings Have Been Initiated Against Erytech by Akkadian to Obtain the Postponement of the Vote on the Merger With Pherecydes	Businesswire
05-Jun-2023	Transgene Presents Immunological Data Demonstrating that TG4001, a Novel Therapeutic Cancer Vaccine, Can Induce T-cell Responses Against HPV16 Antigens in the Ongoing Phase II Trial at ASCO 2023	Businesswire
05-Jun-2023	Novo Nordisk Enters Into Exclusive Negotiations to Acquire a Controlling Stake in BICORP, to Be Followed by a Tender Offer on All Remaining Shares.	Businesswire
05-Jun-2023	VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor, VIC-1911, and G12C Inhibitor, Sotorasib, for KRAS G12C-Mutant Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting	Businesswire
05-Jun-2023	BrainChip and Lorser Industries to Develop Neuromorphic Computing Systems for Software-Defined Radio Devices	Businesswire
04-Jun-2023	Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in Cancer Care	Businesswire
04-Jun-2023	Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer at the 2023 ASCO Annual Meeting	Businesswire
04-Jun-2023	Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer	Businesswire
04-Jun-2023	Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Development and Clinical Practice	Businesswire
03-Jun-2023	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study	Businesswire
03-Jun-2023	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study	Businesswire
03-Jun-2023	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf of Investors	Businesswire